This study presents the first comprehensive pan-cancer analysis of ZNF433, integrating multi-dimensional data including gene expression profiles, genetic alterations, prognostic relevance, tumor immune microenvironment, and drug sensitivity to investigate its potential roles in different malignancies. This evidence concerns the gene ZNF433 and cancer.